Eli Lilly announced a partnership with chipmaker NVIDIA on Tuesday to build what it claims will be the 'most powerful supercomputer owned and operated by a pharmaceutical company.' Lilly's technology investment is meant to help the drugmaker tap into the potential of artificial intelligence for drug discovery.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
